The 4 most recent market catalysts affecting $NIKI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 14, 2026
Corporate Catalyst
Neutral
Impact 65
Niki BioSolutions' DiamiR Announces Engagement Of Fios Genomics For Bioinformatics And Biostatistics Analysis Supporting Alzheimer's Disease Program; Terms Not Disclosed
This announcement is a positive development for Niki BioSolutions (NIKI) as it indicates tangible progress in their Alzheimer's disease program. Engaging a specialized firm like Fi…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 55
Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.
This headline indicates a positive development for Niki BioSolutions, as its subsidiary DiamiR Biosciences has secured a new agreement. This provides a clear revenue stream and val…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 55
Niki BioSolutions’ DiamiR Biosciences Agrees To Provide Progressive Medical Research With Apolipoprotein E Genotyping Services In Support Of Ongoing Clinical And Translational Research Programs
Niki BioSolutions' wholly-owned subsidiary, DiamiR Biosciences, has secured an agreement to provide Apolipoprotein E (APOE) genotyping services to Progressive Medical Research (PMR…
Jul 21, 2026
Corporate Catalyst
Bearish
Impact 75
Niki BioSolutions Shares Halted On Circuit Breaker To The Upside, Stock Now Up 13.36%
The circuit breaker halt to the upside for Niki BioSolutions signifies a sudden and substantial positive price movement, likely triggered by a significant corporate event such as a…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.